Travaux scientifiques

Uzm. Dr. Bülent Kantarcıoğlu

65 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. The Role of Circulating MicroRNAs as Biomarkers and Therapeutic Targets in Venous Thromboembolism: A Systematic Review

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15166306 PMID 42652709 Texte intégral en libre accèsSource : Europe PMC

  2. Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literature

    Thrombosis journal, 2026

    DOI 10.1186/s12959-026-00846-9 PMID 41736014 Texte intégral en libre accèsSource : Europe PMC

  3. Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2026

    DOI 10.1177/10760296251407689 PMID 41773945 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  4. Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.106633 PMID 42293734 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  5. PB2552 Cytokine-Driven and Immune-Inflammatory Signatures Predicts Early Mortality in Acute Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.105292 Texte intégral en libre accèsSource : OpenAlex

  6. Plasminogen Activator Inhibitor-1 and Mean Platelet Volume as Potential Indicators of Prothrombotic State in Immune Thrombocytopenia: An Exploratory Study

    Medical Sciences, 2026

    DOI 10.3390/medsci14070712 Texte intégral en libre accèsSource : OpenAlex

  7. Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241253844 PMID 38755956 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  8. Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241261076 PMID 39043231 Texte intégral en libre accèsSource : Europe PMC

  9. Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241263858 PMID 39140866 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  10. Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241296138 PMID 39654486 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  11. Abstract 4146705: Thrombo-inflammatory biomarker and blood cellular indices are predictive of 30-day mortality Outcome in Patients with Acute Pulmonary Embolism

    Circulation, 2024

    DOI 10.1161/circ.150.suppl_1.4146705 1 citation (OpenAlex) Source : OpenAlex

  12. Relevance of Blood Cellular Indices with Inflammatory Cytokines in Patients with Pulmonary Embolism

    Blood, 2024

    DOI 10.1182/blood-2024-208723 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  13. Abstract 4141580: Prognostic value of blood cellular indices for 30-day mortality in patients with acute pulmonary embolism. Study from the RIETE Registry.

    Circulation, 2024

    DOI 10.1161/circ.150.suppl_1.4141580 Source : OpenAlex

  14. Ultrasound Accelerated Catheter Directed Thrombolytic Therapy in a 15-Year-old Pulmonary Embolism Patient with CLOVES Syndrome

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296221149986 PMID 36650702 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  15. The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231169512 PMID 37062946 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  16. Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231165055 PMID 36941787 10 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  17. Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231165058 PMID 36941804 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  18. PB0121 Relationship of Thrombo-Inflammatory Biomarkers with Oxidative Stress Level in Non-Small Cell Lung Cancer Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.100928 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  19. INTERPLAY OF ADHESION MOLECULES WITH THROMBO-INFLAMMATORY PROCESSES IN PULMONARY EMBOLISM

    Journal of the American College of Cardiology, 2023

    DOI 10.1016/s0735-1097(23)02477-4 Texte intégral en libre accèsSource : OpenAlex

  20. #2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS

    Nephrology Dialysis Transplantation, 2023

    DOI 10.1093/ndt/gfad063c_2728 Texte intégral en libre accèsSource : OpenAlex

  21. INTERCONNECTION BETWEEN THROMBO-INFLAMMATORY AND OXIDATIVE STRESS-RELATED BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

    CHEST Journal, 2023

    DOI 10.1016/j.chest.2023.07.2759 Texte intégral en libre accèsSource : OpenAlex

  22. ENDOTHELIAL DYSREGULATION MEDIATORS IN MEDIATING HEMOSTATIC AND INFLAMMATORY IMBALANCE IN CANCER-ASSOCIATED THROMBOSIS

    CHEST Journal, 2023

    DOI 10.1016/j.chest.2023.07.3870 Texte intégral en libre accèsSource : OpenAlex

  23. Abstract P3021: Circulating Exosomal MicroRNAs As Biomarkers For Pulmonary Embolism

    Circulation Research, 2023

    DOI 10.1161/res.133.suppl_1.p3021 Source : OpenAlex

  24. PB1209 Thrombo-Inflammatory and Fibrinolytic Deficit Biomarkers and their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101035 Texte intégral en libre accèsSource : OpenAlex

  25. PB1327 Bioequivalence of a Generic Version of rFVIIa (Aryoseven) as Compared to the Branded Version of rFVIIa (Novoseven)

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101239 Texte intégral en libre accèsSource : OpenAlex

  26. PB1018 Inter-Relationship of Adhesion Molecules with Thrombo-Inflammatory Processes in Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101816 Texte intégral en libre accèsSource : OpenAlex

  27. PB0968 Thrombo-Inflammatory Biomarkers and Coagulation Factors Contributes to the Hypercoagulable State in Lung Cancer Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101724 Texte intégral en libre accèsSource : OpenAlex

  28. PB0452 Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro- Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101808 Texte intégral en libre accèsSource : OpenAlex

  29. Abstract 16961: Characterization of Extracellular Vesicles and RNA Content and Its Relevance to Thrombo-Inflammatory Biomarkers in Patients With Acute Pulmonary Embolism

    Circulation, 2023

    DOI 10.1161/circ.148.suppl_1.16961 Source : OpenAlex

  30. Abstract 16964: Predictive Value of Blood Cellular Indices for 30-day Mortality in Patients With Acute Pulmonary Embolism. Data From the RIETE Registry

    Circulation, 2023

    DOI 10.1161/circ.148.suppl_1.16964 Source : OpenAlex

  31. Differences in Vascular Access Can Influence the Level of Thrombo-Inflammation and Oxidative Stress in Patients with Hemodialysis

    Journal of the American Society of Nephrology, 2023

    DOI 10.1681/asn.20233411s1540b Source : OpenAlex

  32. Duration of Hemodialysis as an Amplifier of Thrombolytic Deficit and Oxidative Stress in ESRD

    Journal of the American Society of Nephrology, 2023

    DOI 10.1681/asn.20233411s1889c Source : OpenAlex

  33. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221091770 PMID 35360982 4 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  34. Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221145181 PMID 36514257 7 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  35. Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221104801 PMID 35733366 6 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  36. Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221144047 PMID 36474353 3 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  37. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296211056648 PMID 35167393 24 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  38. Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221113346 PMID 35866197 19 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  39. Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221138297 PMID 36476125 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221115112 PMID 35848566 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. Safety and efficacy of currently used COVID‐19 vaccines: Results of a pilot survey

    The FASEB Journal, 2022

    DOI 10.1096/fasebj.2022.36.s1.r3664 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  42. Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution

    The FASEB Journal, 2022

    DOI 10.1096/fasebj.2022.36.s1.r4995 Source : OpenAlex

  43. Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events

    Blood, 2022

    DOI 10.1182/blood-2022-168365 Texte intégral en libre accèsSource : OpenAlex

  44. The Impact of Glycemic Control in Thrombo-Inflammatory Biomarkers in Diabetic Pulmonary Embolism Patients

    Blood, 2022

    DOI 10.1182/blood-2022-165694 Source : OpenAlex

  45. Endogenous Thrombin Generation Potential in Patients with Pulmonary Embolism and Its Relevance to Thrombo-Inflammatory Biomarkers

    Blood, 2022

    DOI 10.1182/blood-2022-165810 Source : OpenAlex

  46. The Role of Blood Cellular Indices in Diabetic Pulmonary Embolism Patients in Predicting Adverse Outcomes

    Blood, 2022

    DOI 10.1182/blood-2022-165765 Source : OpenAlex

  47. A Generic Version of rFVIIa Is Bioequivalent to the Branded Version of rFVIIa

    Blood, 2022

    DOI 10.1182/blood-2022-170935 Source : OpenAlex

  48. Abstract 10876: Thrombo-Inflammatory Biomarkers in Pulmonary Embolism as Stratified in Cancer and Non-Cancer Patient Groups

    Circulation, 2022

    DOI 10.1161/circ.146.suppl_1.10876 Source : OpenAlex

  49. Thromboinflammatory Biomarkers and Their Relationship With Circulating Glycosaminoglycans in ESRD Patients

    Journal of the American Society of Nephrology, 2022

    DOI 10.1681/asn.20223311s1712c Source : OpenAlex

  50. Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2021

    DOI 10.1177/10760296211066942 PMID 34905980 4 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC